International: Page 22

Cannabis Therapy Linked to Reduction of ADHD Medications in Patients

A new study out of Israel points to improved symptoms and a reduction of conventional medications for ADHD patients after cannabis consumption.

Medical Cannabis Exports in Colombia Promise Massive Market Potential

“Colombia will be a world leader in cannabis in a few years," a national cannabis association leader tells CBT.

European Union Urges Member Nations to Vote for World Health Organization’s Cannabis Rescheduling Recommendations

Michael Sassano, chairman of the board for Somai Pharmaceuticals, discusses the news and its impact on both the Ireland-based holding company and the broader international market.

CBG and CBC Kill Gastrointestinal Cancer Cells in Preliminary Study

Funded by U.S. company Cannabics Pharmaceuticals, a firm focused on the development of cannabinoid therapies for cancer treatment, Israeli researchers have demonstrated the anti-tumor efficacy of CBG and CBC against human gastrointestinal cancer cell lines.

Medical Cannabis Is Now Free in Sicily

Sicily’s health chief, Ruggero Razza, signed a decree Jan. 21 that will now allow medical cannabis patients free access to medical cannabis.

Super Drugs for Superbugs: How Cannabinoid Science Links CBG to MRSA Treatment

For nearly 40 years, the antimicrobial effects of cannabis-sourced compounds have been known to researchers. A new study sheds light on the particularly potent efficacy of an up-and-coming cannabinoid, CBG.

Aphria Inc. Receives EU GMP Certification for Subsidiary ARA-Avanti Rx Analytics

The certification allows the company to begin to supply medical cannabis across the European Union, with the first shipment expected to occur in the fourth quarter.

Purpose Investments Inc. Launches Europe’s First Cannabis ETF in Partnership with HANetf

The fund listed Jan. 14 on the Deutsche Boerse XETRA exchange in Germany.

Global Cannabis Sales Grow 48% to $15 Billion in 2019

The cannabis market on track to reach $43 billion in 2024.

Newly Discovered Natural Cannabinoid THCP Offers Greater Potency Than THC

Recently published work from an Italian research team describes how THCP may help scientists understand why some cannabis chemovars are more potent than others.

Pre-Clinical Study Suggests CBG Is More Effective Than CBGA on Stomach and Bone Cancers

Researchers at Cannabics Pharmaceuticals in Israel have announced preliminary findings that show CBG may be more effective against human stomach and bone cancer cell lines than the acidic precursor, CBGA.

Here Are the 12 Canadian Cannabis Companies That Trade on U.S. Stock Markets

FSD Pharma, a Toronto-based biotech pharmaceutical R&D company, garnered a Nasdaq uplisting this winter and began trading on the U.S. market Jan. 9.

Previous Page

Page 22 of 63

Next Page